dc.contributor.author | Kouijzer, IJE | |
dc.contributor.author | Mulders-Manders, CM | |
dc.contributor.author | Bleeker-Rovers, CP | |
dc.contributor.author | Oyen, WJG | |
dc.date.accessioned | 2017-11-27T16:06:28Z | |
dc.date.issued | 2018-03 | |
dc.identifier.citation | Seminars in nuclear medicine, 2018, 48 (2), pp. 100 - 107 | |
dc.identifier.issn | 0001-2998 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/955 | |
dc.identifier.eissn | 1558-4623 | |
dc.identifier.doi | 10.1053/j.semnuclmed.2017.11.004 | |
dc.description.abstract | Fever of unknown origin (FUO) is commonly defined as fever higher than 38.3°C on several occasions during at least 3 weeks with uncertain diagnosis after a number of obligatory investigations. The differential diagnosis of FUO can be subdivided in four categories: infections, malignancies, noninfectious inflammatory diseases, and miscellaneous causes. In most cases of FUO, there is an uncommon presentation of a common disease. FDG-PET/CT is a sensitive diagnostic technique for the evaluation of FUO by facilitating anatomical localization of focally increased FDG uptake, thereby guiding further diagnostic tests to achieve a final diagnosis. FDG-PET/CT should become a routine procedure in the workup of FUO when diagnostic clues are absent. FDG-PET/CT appears to be a cost-effective routine imaging technique in FUO by avoiding unnecessary investigations and reducing the duration of hospitalization. | |
dc.format | Print-Electronic | |
dc.format.extent | 100 - 107 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Humans | |
dc.subject | Fever of Unknown Origin | |
dc.subject | Fluorodeoxyglucose F18 | |
dc.subject | C-Reactive Protein | |
dc.subject | Age Factors | |
dc.subject | Cost-Benefit Analysis | |
dc.subject | Positron Emission Tomography Computed Tomography | |
dc.title | Fever of Unknown Origin: the Value of FDG-PET/CT. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2017-11-23 | |
rioxxterms.funder | The Institute of Cancer Research | |
rioxxterms.identifier.project | Unspecified | |
rioxxterms.versionofrecord | 10.1053/j.semnuclmed.2017.11.004 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2018-03 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Seminars in nuclear medicine | |
pubs.issue | 2 | |
pubs.notes | No embargo | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging | |
pubs.publication-status | Published | |
pubs.volume | 48 | |
pubs.embargo.terms | No embargo | |
icr.researchteam | Translational Molecular Imaging | en_US |
dc.contributor.icrauthor | Oyen, Willem | |